Magnesium 2000 postmarket evaluation: Guideline adherence and intraprocedural performance of a sirolimus-eluting resorbable magnesium scaffold-Reference-Cited by-同舟云学术

Magnesium 2000 postmarket evaluation: Guideline adherence and intraprocedural performance of a sirolimus-eluting resorbable magnesium scaffold

Published:2019-12 Issue:12 Volume:20 Page:1140-1145
ISSN:1553-8389
Container-title:Cardiovascular Revascularization Medicine
language:en
Short-container-title:Cardiovascular Revascularization Medicine

Author:

Wlodarczak Adrian,Garcia Luis Antonio Iñigo,Karjalainen Pasi P.,Komócsi András,Pisano Francesco,Richter Stephan,Lanocha Magdalena,Rumoroso Jose Ramón,Leung Kwok Fai

Funder

Biotronik

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference11 articles.

1. State of the art: the inception, advent and future of fully bioresorbable scaffolds;Katagiri;EuroIntervention,2017

2. Bioresorbable scaffold: the emerging reality and future directions;Sotomi;Circ Res,2017

3. Sustained safety and clinical performance of a drug-eluting absorbable metal scaffold up to 24 months: pooled outcomes of BIOSOLVE-II and BIOSOLVE-III;Haude;EuroIntervention,2017

4. Safety and clinical performance of a drug eluting absorbable metal scaffold in the treatment of subjects with de novo lesions in native coronary arteries: pooled 12-month outcomes of BIOSOLVE-II and BIOSOLVE-III;Haude;Catheter Cardiovasc Interv,2018

5. In vitro performance investigation of bioresorbable scaffolds - standard tests for vascular stents and beyond;Schmidt;Cardiovasc Revasc Med,2016

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Magnesium based implants: Alloying and coating strategies for improvement in its biomechanical and biocorrosion properties;Proceedings of the Institution of Mechanical Engineers, Part L: Journal of Materials: Design and Applications;2024-08-29

2. Two-Year Outcomes for Patients with Non-ST-Elevation Acute Coronary Syndrome Treated with Magmaris and Absorb Bioresorbable Scaffolds in Large-Vessel Lesions;Journal of Personalized Medicine;2024-05-17

3. One- and two-year clinical outcomes of treatment with resorbable magnesium scaffolds for coronary artery disease the prospective, international, multicentre BIOSOLVE-IV registry;EUROINTERVENTION;2023

4. Safety and performance of the third-generation drug-eluting resorbable coronary magnesium scaffold system in the treatment of subjects with de novo coronary artery lesions: 6-month results of the prospective, multicenter BIOMAG-I first-in-human study;eClinicalMedicine;2023-05

5. Bioresorbable Magnesium-Based Stent: Real-World Clinical Experience and Feasibility of Follow-Up by Coronary Computed Tomography: A New Window to Look at New Scaffolds;Biomedicines;2023-04-11